Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

553 studies match

clinicaltrialsPublishedShowing 301–350 of 553 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06130553	A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors(PRIMROSE)	recruiting	Phase 1 / Phase 2	334	AstraZenecaINDUSTRY	8	Aug 27, 2026	clinicaltrials
NCT06726148	Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	280	Novartis PharmaceuticalsINDUSTRY	16